Skip to main content

Advertisement

Log in

The grandfather’s fever

  • Case Based Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

An 86-year-old Caucasian man had prior episodes of fever (up to 38 °C), mild abdominal pain, tachycardia, and malaise in the last 3 months, lasting 2–3 days. He never suffered from abdominal or chest pain, rash, or arthralgia. Major causes of fever were excluded (pulmonary, urinary, abdomen, skin infections, neoplasms, and major rheumatologic disorders). The patient was native of Altamura with a family history of familial Mediterranean fever (FMF). The genetic testing confirmed the presence of MEFV gene variants c.442G>C (E148Q) on exon 2 and c.2282G>A (R761H) on exon 10, all in heterozygosity. Mildly elevated serum transaminases suggested an ongoing form of FMF hepatitis on nonalcoholic liver steatosis. The patient started colchicine 1 mg/day that induced symptom control and normalization of inflammatory markers, hyperbilirubinemia, and markers of cholestasis. Symptoms of FMF can appear at any age in life and our patient represents a very late-onset clinical case. The Apulian region has a consistent clustering of MEFV variants and FMF families with affected individuals in multiple consecutive generations. Families show unique clinical features and rare signs of secondary amyloidosis without kidney damage. Genetic and environmental bases of this phenotypic variant are under scrutiny. Colchicine lifetime remains the mainstay of treatment in FMF patients.

Key Points

Familial Mediterranean fever (FMF) is the most frequent hereditary monogenic recurrent fever syndrome, and symptoms can appear at any age in life.

Late-onset FMF approaches 30% in late adulthood, but in general, onset of FMF after the age of 40 (late onset FMF) is rare, usually associated with M694V heterozygosity.

In a local cluster of FMF families (Altamura, Puglia, Southern Italy), we report a very late-onset FMF (variants E148Q, R761H) in an 86-year-old patient with a positive family history of FMF in two generations of descendants.

While lifetime colchicine remains the mainstay of treatment in FMF patients, prospective studies need to identify the characteristics of several phenotypic variants accounting for (very)-late onset FMF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bonfrate L, Scaccianoce G, Palasciano G, Ben-Chetrit E, Portincasa P (2017) A novel cluster of patients with familial Mediterranean fever (FMF) in southern Italy. Eur J Clin Investig 47:622–629

    Article  CAS  Google Scholar 

  2. Ben-Chetrit E, Touitou I (2009) Familial Mediterranean fever in the world. Arthritis Rheum 61:1447–1453

    Article  CAS  Google Scholar 

  3. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, Ozdogan H, Abu I, Gattorno M, Hawkins PN, Yuce S, Kallinich T, Bilginer Y, Kastner D, Carmona L (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644–651

    Article  CAS  Google Scholar 

  4. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885

    Article  CAS  Google Scholar 

  5. Portincasa P, Scaccianoce G, Palasciano G (2013) Familial Mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Investig 43:1314–1327

    Article  CAS  Google Scholar 

  6. Moradian MM, Sarkisian T, Ajrapetyan H, Avanesian N (2010) Genotype-phenotype studies in a large cohort of Armenian patients with familial Mediterranean fever suggest clinical disease with heterozygous MEFV mutations. J Hum Genet 55:389–393

    Article  CAS  Google Scholar 

  7. The International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797–807

    Article  Google Scholar 

  8. The French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31

    Article  Google Scholar 

  9. Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, Ahmed-Arab M, Dross C, Dupont M, Cattan D, Smaoui N, Dodé C, Pêcheux C, Nédelec B, Medaxian J, Rozenbaum M, Rosner I, Delpech M, Grateau G, Demaille J, Weissenbach J, Touitou I (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet 7:1317–1325

    Article  CAS  Google Scholar 

  10. Stella A, Cortellessa F, Scaccianoce G, Pivetta B, Settimo E, Portincasa P (2019) Familial Mediterranean fever: breaking all the (genetic) rules. Rheumatology (Oxford) 58:463–467

    Article  Google Scholar 

  11. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I, Costa JM, de Leener A, Gattorno M, Kania U, Kone-Paut I, Lezer S, Livneh A, Moix I, Nishikomori R, Ozen S, Phylactou L, Risom L, Rowczenio D, Sarkisian T, van Gijn ME, Witsch-Baumgartner M, Morris M, Hoffman HM, Touitou I (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71:1599–1605

    Article  CAS  Google Scholar 

  12. Witsch-Baumgartner M, Touitou I (2015) Clinical utility gene card for: prototypic hereditary recurrent fever syndromes (monogenic autoinflammatory syndromes). Eur J Hum Genet 23:1111

    Article  Google Scholar 

  13. Tsuchiya-Suzuki A, Yazaki M, Nakamura A et al (2009) Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol 36:1671–1676

    Article  CAS  Google Scholar 

  14. Van Gijn ME, Ceccherini I, Shinar Y et al (2018) New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID). J Med Genet 55:530–537

    Article  Google Scholar 

  15. Ozturk C, Halicioglu O, Coker I et al (2012) Association of clinical and genetical features in FMF with focus on MEFV strip assay sensitivity in 452 children from western Anatolia, Turkey. Clin Rheumatol 31:493–501

    Article  Google Scholar 

  16. Mattit H, Joma M, Al-Cheikh S et al (2006) Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. Eur J Med Genet 49:481–486

    Article  Google Scholar 

  17. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, Kartalis G, Speletas M, Ritis K (2007) MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 71:458–467

    Article  CAS  Google Scholar 

  18. Cantarini L, Capecchi PL, Lucherini OM, Laghi Pasini F, Galeazzi M (2010) Familial Mediterranean fever diagnosed in an elderly patient. Clin Exp Rheumatol 28:S91

    PubMed  Google Scholar 

  19. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, Pras M, Pras E (2009) Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology 60:1862–1866

    Article  CAS  Google Scholar 

  20. Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 43:227–253

    Article  CAS  Google Scholar 

  21. Sayarlioglu M, Cefle A, Inanc M et al (2005) Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases. Int J Clin Pract 59:202–205

    Article  CAS  Google Scholar 

  22. Tamir N, Langevitz P, Zemer D, Pras E, Shinar Y, Padeh S, Zaks N, Pras M, Livneh A (1999) Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics. Am J Med Genet 87:30–35

    Article  CAS  Google Scholar 

  23. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E, Turkish FMF Study Group (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11

    Article  Google Scholar 

  24. Levy M, Eliakim M (1977) Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J 2:808

    Article  CAS  Google Scholar 

  25. Yamane T, Uchiyama K, Hata D, Nakamura M, Ishii T, Koido S, Fujise K, Tajiri H (2006) A Japanese case of familial Mediterranean fever with onset in the fifties. Intern Med 45:515–517

    Article  Google Scholar 

  26. Erten S (2016) Familial Mediterranean fever patient with onset of attacks at the age of seventies. Journal of Clinical and Analytical Medicine 7:109

    Article  Google Scholar 

  27. Al-Khafaji J, Ganz-Lord F, Konjeti VR, Viny AD (2018) A case of familial Mediterranean fever with extensive lymphadenopathy and complex heterozygous genotype presenting in the fourth decade. Case Rep Rheumatol 2018:9670801

    PubMed  PubMed Central  Google Scholar 

  28. Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A (2018) Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: data from a multicenter, prospective national cohort study in Japan. Arthritis Res Ther 20:257

    Article  CAS  Google Scholar 

  29. Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y (2019) Late-onset familial Mediterranean fever in Japan. Mod Rheumatol:1–4

  30. Aydin O, Ugurlu S, Ozdogan H (2019) THU0590 comparison of FMF patients with age of onset before 20 versus 40 years and over. Ann Rheum Dis 78:586

    Article  Google Scholar 

  31. Migita K, Agematsu K, Yazaki M, Nonaka F, Nakamura A, Toma T, Kishida D, Uehara R, Nakamura Y, Jiuchi Y, Masumoto J, Furukawa H, Ida H, Terai C, Nakashima Y, Kawakami A, Nakamura T, Eguchi K, Yasunami M, Yachie A (2014) Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore) 93:158–164

    Article  CAS  Google Scholar 

  32. Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S (2014) Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther 16:439

    Article  Google Scholar 

  33. Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664

    Article  CAS  Google Scholar 

  34. Korkmaz C, Kasifoglu T (2007) Changes in the liver function tests during the attacks of familial Mediterranean fever. Rheumatol Int 27:395–398

    Article  Google Scholar 

  35. Ben-Chetrit E, Yazici H (2017) The liver in familial Mediterranean fever: is it involved? Clin Exp Rheumatol 35:S108–S112

    Google Scholar 

  36. Portincasa P (2016) Colchicine, biologic agents and more for the treatment of familial Mediterranean fever. The old, the new, and the rare. Curr Med Chem 23:60–86

    Article  CAS  Google Scholar 

  37. Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P (2014) Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther 95:89–97

    Article  CAS  Google Scholar 

  38. Wang D, Bonfrate L, de Bari O, Wang T, Portincasa P (2014) Familial Mediterranean fever: from pathogenesis to treatment. J Genet Syndr Gene Ther 5:2

    Google Scholar 

  39. Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, Koné-Paut I, Dewarrat N, Cantarini L, Insalaco A, Uziel Y, Rigante D, Quartier P, Demirkaya E, Herlin T, Meini A, Fabio G, Kallinich T, Martino S, Butbul AY, Olivieri A, Kuemmerle-Deschner J, Neven B, Simon A, Ozdogan H, Touitou I, Frenkel J, Hofer M, Martini A, Ruperto N, Gattorno M, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Eurofever Project (2015) Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis 74:799–805

    Article  Google Scholar 

  40. Yenokyan G, Armenian HK (2012) Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. Am J Epidemiol 175:1054–1061

    Article  Google Scholar 

Download references

Acknowledgments

We are indebted to Rosanna Bagnulo, Paola De Benedictis, and Rosa De Venuto for skillful technical assistance. We also thank Dr. Paolo Buonamico for clinical management, Prof. Eldad Ben-Chetrit for helpful scientific discussion, and Paolo Calveri, president of Italian Association of Periodic Fevers (AIFP). This work was partly supported from FARB-MIUR grant to AS.

Author information

Authors and Affiliations

Authors

Contributions

PR, AS, ES, FP, FM, AB, VOP, SP, and GS contributed to the clinical, instrumental, and biohumoral workup of the patient. PP wrote the first draft and revised the final version. AS was responsible for the genetic analysis. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Piero Portincasa.

Ethics declarations

Disclosures

None.

Ethics approval

Our institutions do not require ethical approval for reporting individual cases or case series.

Informed consent

Written informed consent was obtained from the patient for his anonymized information to be published in this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ricci, P., Stella, A., Settimo, E. et al. The grandfather’s fever. Clin Rheumatol 39, 585–594 (2020). https://doi.org/10.1007/s10067-019-04741-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04741-9

Keywords

Navigation